Pfs230D1

Pfs230D1 · Serum Institute of India Pvt. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pfs230D1, covering 2026-02-10 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults [Phase 1]